According to the MHRA/EMC SmPC for Wegovy, the most frequently reported gastrointestinal side effects include: Nausea the most common adverse effect, affecting approximately 44% of patients in clinical trials, typically most pronounced during dose escalation Diarrhoea reported in around 30% of patients, ranging from mild to moderate severity Constipation affecting approximately 24% of patients, related to slowed gut transit Vomiting occurring in roughly 24% of patients, often associated with nausea Abdominal pain or discomfort reported by approximately 20% of patients Dyspepsia (indigestion) affecting around 9% of patients Bloating and flatulence commonly reported but less precisely quantified in trials These side effects are dose-dependent , meaning they tend to be more pronounced at higher doses and during the escalation phase

Strategies to Minimize Injection Site Reactions Use Proper Injection Technique: Always wash your hands thoroughly Clean the injection site with alcohol and let it dry Use a fresh, sterile syringe every time Inject slowly and gently Rotate injection sites daily (avoid injecting the same spot more than once per week) Pinch the skin to form a small fold when injecting Avoid injecting into irritated, bruised, or scarred tissue Consider Dilution and Buffering: Some peptides (e.g., CJC-1295, BPC-157) may be more acidic depending on the manufacturer
Thus, there was considerable overlap with the COVID-19 lockdowns starting early 2020, the significance of which cannot be discerned
"I was really struggling to get out on the bike, but when I went out on my bike for the first time, having lost that weight, it was just a game-changer